24 related articles for article (PubMed ID: 26039534)
1. Effectiveness of nurse-led fever, sugar-hyperglycemia, and swallowing bundle care on clinical outcome of patients with stroke at a tertiary care center: A randomized controlled trial.
Sridhar D; Ramamoorthy L; Narayan SK; Amalnath D; Lalthanthuami HT; Ganapathy S; Puliyakkuth U
J Neurosci Rural Pract; 2024; 15(2):255-261. PubMed ID: 38746518
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive cytoprotective therapies in acute ischemic stroke: a systematic review.
Mulder IA; van Bavel ET; de Vries HE; Coutinho JM
Fluids Barriers CNS; 2021 Oct; 18(1):46. PubMed ID: 34666786
[TBL] [Abstract][Full Text] [Related]
3. The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies.
Wanderer S; Grüter BE; Strange F; Sivanrupan S; Di Santo S; Widmer HR; Fandino J; Marbacher S; Andereggen L
Brain Sci; 2020 Mar; 10(3):. PubMed ID: 32156050
[No Abstract] [Full Text] [Related]
4. Administering the Routine Activities domain of the Oxford Participation and Activities Questionnaire as a stand-alone scale: the Oxford Routine Activities Measure.
Morley D; Dummett S; Kelly L; Jenkinson C
Patient Relat Outcome Meas; 2018; 9():239-243. PubMed ID: 30100772
[TBL] [Abstract][Full Text] [Related]
5. Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Jusufovic M; Sandset EC; Bath PM; Berge E;
J Hypertens; 2016 Aug; 34(8):1594-8. PubMed ID: 27228435
[TBL] [Abstract][Full Text] [Related]
6. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Hornslien AG; Sandset EC; Igland J; Terént A; Boysen G; Bath PM; Murray GD; Berge E
Int J Stroke; 2015 Aug; 10(6):830-5. PubMed ID: 25808741
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke.
Jusufovic M; Sandset EC; Bath PM; Berge E;
Stroke; 2014 Nov; 45(11):3440-2. PubMed ID: 25256183
[TBL] [Abstract][Full Text] [Related]
8. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
[TBL] [Abstract][Full Text] [Related]
9. Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis.
Jusufovic M; Sandset EC; Bath PM; Karlson BW; Berge E;
Int J Stroke; 2015 Apr; 10(3):354-9. PubMed ID: 25472578
[TBL] [Abstract][Full Text] [Related]
10. Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months.
Hornslien AG; Sandset EC; Wyller TB; Berge E;
J Hypertens; 2015 Jul; 33(7):1487-91. PubMed ID: 26039534
[TBL] [Abstract][Full Text] [Related]
11. Candesartan for the prevention and treatment of stroke - results of the SCOPE and ACCESS trials.
Doggrell SA;
Expert Opin Pharmacother; 2004 Mar; 5(3):687-90. PubMed ID: 15013936
[TBL] [Abstract][Full Text] [Related]
12. Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - a review.
Zanchetti A; Elmfeldt D
Blood Press; 2006; 15(2):71-9. PubMed ID: 16754269
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
